care of patients with acute/chronic kidney injury ch 71 Flashcards
onset
difference between acute/chronic
acute: sudden (hours to days)
chronic: gradual (months to years)
% of nephrons involved
difference between acute/chronic
acute: 50%
chronic: 90-95%
duration of disease
difference between acute/chronic
acute: 2-4 weeks, less than 3 months
chronic: permanent
prognosis of disease
difference between acute/chronic
acute: good for return of kidney function with supportive care. high mortality in some situations
chronic: fatal without a renal replacement therapy such as dialysis or transplantation
azotemia
the retention and buildup of nitrogenous wastes in the blood
When BUN rises faster than the serum creatinine level, the cause is usually related to ____
protein breakdown or dehydration
when both the BUN and creatinine levels rise and the ratio between the two remains constant, this indicates ____
kidney dysfunction
causes of pre renal AKI
any condition that decreases blood flow to the kidneys and leads to ischemia in the nephrons
shock (hypovolemia, hemorrhage, distributive, obstructive) HF PE anaphylaxis sepsis pericardial tamponade
most common: shock, HF
causes of intrarenal AKI
actual physical, chemical, hypoxic, immunologic image directly to the kidney tissue
usually occurs with damage to glomeruli, interstitial tissue, or tubules
acute interstitial nephritis exposure to nephrotoxins acute glomerular nephritis vasculitis acute tubular necrosis renal artery or vein stenosis renal artery or vein thrombosis formation of crystals or precipitates in the nephron tubules
normal osmolarity
270-300
HCO3 range
22-26
PaCO2
35-45
early AKI can often be revered by:
correcting blood volume
increasing BP
improving cardiac output
drugs that most often cause intrarenal AKI
aminoglycoside antibiotics (gentamicin, neomycin, streptomycin, kanamycin, tobramycin) NSAIDs
causes of postrenal AKI
obstruction of the urine collecting system anywhere from the calyces to the urethral meatus
obstruction must be bilateral to cause post renal failure, unless only 1 kidney is functional
ureter, bladder, urethral cancer kidney, ureter, bladder stone bladder atony prostatic hyperplasia or cancer urethral stricture cervical cancer
onset phase of AKI
- description
- characteristics
begins with precipitating event and continues until oliguria develops
last hours to days
the gradual accumulation of nitrogenous wastes, such as increasing serum creatinine and BUN
oliguric phase of AKI
- description
- characteristics
characterized by urine output of 100-400 mL/24 hr that does not respond to fluids or diuretics
lasts 1-3 weeks
increasing serum creatinine and BUN
hyperkalemia, metabolic acidosis, hyperphosphatemia, hypocalcemia, hypermagnesemia
sodium retention
urine specific gravity and urine osmolarity do not vary as plasma osmolarity changes
diuretic phase of AKI
- description
- characteristics
high output phase
often has a sudden onset within 2-6 wk after oliguric stage
urine flow increases rapidly over a period of several days
diuresis can result in an output of 10 L/day of dilute urine
BUN levels start to fall and continues till it reaches normal levels
normal kidney tubular function is re-established
recovery phase of AKI
- description
- characteristics
patient begins to return to normal levels of activity
complete recover can take up to 12 months
manifestations of volume depletion
yellow box 1541
low urine output decreased systolic BP decreased pulse pressure orthostatic hypotension thirst rising blood osmolarity
potential nephrotoxic substances
rifampin vancomycin ibuprofen ketorolac naproxen tylenol captopril metformin myoglobin
manifestations of prerenal azotemia AKI
hypotension tachycardia decreased cardiac output decreased central venous pressure decreased urine output lethargy
renal manifestations of intrarenal/postrenal AKI
oliguria or anuria
increased urine specific gravity
cardiac manifestations of intrarenal/postrenal AKI
HTN tachycardia JVD increased central venous pressure tall T waves
respiratory manifestations of intrarenal/postrenal AKI
SOB orthopnea crackles pulmonary edema friction rub
gastrointestinal manifestations of intrarenal/postrenal AKI
anorexia
n/v
flank pain
neurologic manifestations of intrarenal/postrenal AKI
lethargy
headache
tremors
confusion
lab values in pt with prerenal azotemia
BUN/creatine ration of greater than 20 sodium often less than 10-20 urine concentrated urine sediment (RBCs, RBC casts, tubular cells) myoglobin, hemoglobin
lab values for intrarenal problem
BUN/creatine ration less than 15
urine sodium less than 40
specific gravity less than 1.01
lab values for postrenal problem
urine sodium may be normal
specific gravity 1.000-1.010
main problems during the oliguric phase
close monitoring for life threatening electrolyte changes and nitrogen retention
problems during the diuretic phase
hypovolemia
electrolyte loss
what do calcium channel blockers do in AKI
can be given if caused by nephrotoxic acute tubular necrosis
prevent movement of calcium into the kidney cells, maintain kidney cell integrity, improve the GFR by improving kidney blood flow
action/purpose of Digoxin (cardiac glycosides) for kidney disease
digoxin (Lanoxin)
used when HF induces kidney injury/disease or makes it worse
Improves ventricular contraction, increasing stroke volume and cardiac output
do not take antacids within 2 hrs
folic acid (Vitamin B9) -action/purpose
when pt is receiving dialysis, many essential vitamins and minerals are removed from the blood. replacement is needed to prevent deficiencies
ferrous sulfate
action/purpose
when pt is receiving dialysis, many essential vitamins and minerals are removed from the blood. replacement is needed to prevent deficiencies
take with meals, daily stool softeners
epoetin alfa (Epogen, Procrit)
-action/purpose
synthetic erythropoietin
drug prevents anemia by stimulating RBC growth and maturation in the bone marrow
epoetin alfa (Epogen, Procrit)
-nursing interventions
teach pt to report any side effects as soon as possible: chest pain, difficulty breathing, high BP, rapid weight gain, seizures, rash, hives, swelling of feet or ankles (drug can induce cardiovascular problems such as an MI)
must have hemoglobin levels monitored weekly
two types of synthetic erythropoietin
epoetin alfa (Procrit, Epogen)
darbepoeitin alfa (Aranesp)
types of phosphate binders
aluminum hydroxide gel (Amphojel)
aluminium carbonate gel (Basalijel)
purpose of phosphate binders
high blood phosphate levels cause hypocalcemia and osteodystrophy. drugs lower serum phosphate levels by binding phosphorus present in food
phosphate binders
nursing interventions
take with meals (drug binds to phosphate in food)
take digoxin 2 hours before/after
take stool softeners
report muscle weakness, slow or irregular pulse, confusions (manifestations of hypophosphatemia)
key features of uremia
1547
metallic taste in mouth anorexia n/v muscle cramps uremic frost on skin itching fatigue lethargy hiccups edema dyspnea muscle cramps paresthesias
GFR of >90
-what is stage of CKD
stage 1
at risk; normal kidney function
early kidney disease may or may not be present
GFR 60-89
-what is stage of CKD
stage 2
mild CKD
may be slight elevation of metabolic wastes in the blood. Increased urinary output of dilute urine may occur, and if untreated, can cause dehydration
stage 1 CKD
interventions
screen for risk factors: uncontrolled HTN DM chronic kidney or UTI presence of genetic kidney diseases exposure to nephrotoxic substances
stage 5 CKD
end stage kidney disease
interventions
implement renal replacement therapy
kidney transplantation
rate of creatinine exception depends on
muscle mass
physical activity
diet
the method for assessing the GFR is the use of a formula that considers:
serum creatinine level age gender race body size
neurologic manifestations of CKD
lethargy, seizures, coma= uremic encephalopathy daytime drowsiness inability to concentrate slurred speech asterixis tremors, twitching, jerky movements myoclonus ataxia paresthesias
cardiovascular manifestations of CKD
- result from:
- examples:
result from fluid overload, HTN, HF, pericarditis, K induced dysrhythmias
cardiomyopathy HTN peripheral edema HF uremic pericarditis pericardial effusion pericardial friction rub cardiac tamponade
respiratory manifestations of CKD
uremic halitosis tachypnea deep sighing, yawning Kussmaul respirations uremic pneumonitis SOB pulmonary edema pleural effusion depressed cough reflex crackles
hematologic manifestations of CKD
anemia
abnormal bleeding and bruising
GI manifestations of CKD
anorexia n/v metallic taste in the mouth change sin taste acuity and sensation uremic colitis (diarrhea) constipation uremic gastritis possible GI bleeding breath odor stomatitis
urinary manifestations of CKD
polyuria nocturia (early) oliguria anuria (late) proteinuria hematuria diluted straw colored appearance (early) concentrated and cloudy appearance (later)
integumentary manifestations of CKD
decreased skin turgor yellow gray pallor dry skin pruritus ecchymosis purpura soft tissue calcifications uremic forst (late, premorbid)
musculoskeletal manifestations of CKD
muscle weakness and cramping
bone pain
pathologic fractures
renal osteodystrophy
reproductive manifestations of CKD
decreased fertility
infrequent or absent menses
decreased libido
impotence
priority problems for pts with CKD
fluid overload potential for pulmonary edema decreased cardiac output inadequate nutrition potential of infection potential for injury fatigue anxiety
early s/s of pulmonary edema
restlessness anxiety rapid HR SOB crackles the begin at base of lungs frothy pink tinged sputum
CKD and pulmonary edema
- nuring interventions
furosemide given cautiously
measure urine output q15-30 minutes during acute episode
assess breath sounds q2 hrs
IV morphine to reduce myocardial oxygen demand
dietary protein recommendations
-for pt with chronic uremia
0.55-0.60 g/kg/day
least amount of protein, compared to other conditions
dietary protein recommendations
- for pt with hemodialysis
1-1.5 g/kg/day
dietary protein recommendations
- for pt with peritoneal dialysis
1.2-1.5 g/kg/day
slightly higher compared to other 2
fluid recommendations
- for pt with chronic uremia
depends on urine output but may be as high as 1500-3000 mL/day
(pt can drink more fluid with this than other two conditions)
fluid recommendations
- for pt with hemodialysis
500-700 mL/day plus amount of urine output
fluid recommendations
- for pt with peritoneal dialysis
restriction based on fluid weight gain and BP
potassium recommendations
- for pt with chronic uremia
60-70 mEq/day
least amount of K+ compared to other conditions
potassium recommendations
- for pt with hemodialysis
70
potassium recommendations
- for pt with peritoneal dialysis
usually no restriction
sodium recommendations
- for pt with chronic uremia
1-3 g/day
lowest restriction compared to other conditions
sodium recommendations
- for pt with hemodialysis
2-4 g
sodium recommendations
- for pt with peritoneal dialysis
based on fluid wt gain and BP
complications of hemodialysis
disequilibrium syndrome muscle cramps hemorrhage air embolus hypotension anemia cardiac dysrhythmias infection
complications of peritoneal dialysis
protein loss peritonitis hyperglycemia respiratory distress bowel perforation infection
hemodialysis is started on these patients immediately
fluid overload that doesn't respond to diuretics pericarditis uncontrolled HTN neurologic problems development of bleeding
complications of AV access
thrombosis stenosis infection aneurysm formation ischemia HF
s/s of disequilibrium syndrome
headache nausea vomiting restlessness decreased LOC seizures coma death
treatment for disequilibrium syndrome
anticonvulsants
barbiturates
manifestations of peritonitis
cloudy dialysate outflow (earliest sign) fever abd tenderness abd pain general malaise n/v
post of care following kidney transplant
monitor output at least hourly for 48 hours
urine pink/bloody right away, gradually turns normal over several days to weeks
catheter might be used, remove in 3-7 days
mannitol may be prescribed
q2-4 hrs: measure BP, I&O
clinical manifestations of hyperacute rejection
increased temp
increased BP
pain at transplant site
clinical manifestations of acute rejection
oliguria or anuria temp over 100 increased BP enlarged tender kidney lethargy increased creatinine, BUN, K+ fluid retention